Humasis participates Dubai MEDLAB Middle East 2023

South Korean medical devices maker, Humasis Co., is participating in the MEDLAB Middle East 2023 event taking place at the Dubai World Trade Center ...

SK Innovation steps up carbon offset, green investments

SK Innovation Co., the refinery and chemicals unit of South Korea’s second-largest conglomerate SK, is poised to strengthen its eco-friendly b...

Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US

South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...

Bridge Biotherapeutics, Pinotbio develop lung cancer treatment

South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...

HK inno.N to introduce biosimilars for bone disease treatment from Spain

South Korea's biohealth company HK inno.N said on Wednesday that it has signed an agreement with Spanish pharmaceutical company mAbxience SA to intr...

Inventage Lab launches clinical trials for addiction treatment in Australia

South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...

ST Pharm exports $14.6 mn worth of drug ingredients to Europe

ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...

LG Chem completes acquisition of US biotech firm AVEO

LG Chem Ltd. is set to complete its $571 million purchase of the US biotech firm AVEO Pharmaceuticals Inc. on Friday, which would strengthen its ant...

GC Biopharma's Sanfilippo treatment eligible for FDA priority review

GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...

Samsung to open Galaxy Experience Spaces for Galaxy Unpacked

Samsung Electronics Co. will open 29 interactive Galaxy Experience Spaces in 24 locations in 19 countries, following the Galaxy Unpacked event to be...

SK Innovation-invested Amogy tests ammonia-powered heavy truck

Amogy Inc. has successfully tested its ammonia-hydrogen power system for large-size semi trucks – the first time that ammonia has been used as...

MedPacto's anti-cancer substance designated as US FDA fast-track item

South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...

Bespin Global establishes Vietnam Tech Center for cloud, digital innovation

South Korea's cloud management company Bespin Global will foster cloud and digital innovation industries in Central Vietnam. To this end, the compan...

Celltrion applies for EMA approval of smaller dose formulation of Yuflyma

Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...

SK Chemicals launches uremia itching treatment tablet

SK Chemicals said on Monday that it has launched Remitch in orally disintegrating tablets, a treatment for intractable uremic pruritus (uremia itchi...

Elon Musk’s vision for Korean innovation isn’t crazy

For a “genius,” Elon Musk sure does say lots of mindless things. Yet on any list of the least crazy ideas from the Tesla founder, his take...

S.Biomedics gets approval for Parkinson's disease clinical trials

South Korea's biomedicine firm S.Biomedics said on Friday that it has won approval from the Ministry of Food and Drug Safety for phase 1 and 2a clin...

HK inno.N gets approval to sell K-CAB in Singapore

South Korean biohealth company HK inno.N said on Wednesday that it has received an item approval for K-CAB, a new drug for gastroesophageal reflux d...

Prestige Biopharma attains patent for solid cancer treatment antibody

Prestige Biopharma Korea said on Tuesday that it has obtained a domestic patent for the CTHRC1 neutralizing antibody of the drug candidate PBP1710. ...

SK Ecoplant looks to enter US battery recycling business: CEO

SK Ecoplant Co., a South Korean construction engineering company, will enter the US battery recycling business by investing in promising startups, C...

Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments

Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...

Hyundai Motor Group to make debuts of innovative startups at CES

Hyundai Motor Group's open innovation platform Zero1ne will showcase innovative technologies from ten South Korean startups at CES 2023, the world's...

Korean startups win 4 out of 23 Best of Innovations at CES 2023

LAS VEGAS – South Korean startups have won four out of the 23 Best of Innovation awards from Consumer Technology Association (CTA), which host...

NeoImmuneTech, US think tank to develop treatment for acute radiation syndrome

Biopharmaceutical company NeoImmuneTech has grabbed an opportunity to supply new drug candidates in development as strategic items to the US gover...

Seoul Viosys receives CES Display Innovation Award

Seoul Viosys Co. said on Tuesday that it received the Innovation Award in the display category for a component called "WICOP pixel" at CES 2023, the...

Celltrion's Remsima receives approval in 100 countries in 10 years

South Korea's most valuable biopharmaceutical company Celltrion Inc. said on Tuesday that its antibody biosimilar Remsima (ingredient: infliximab) h...

HLB confirms ophthalmic disease treatment in phase 3 clinical trials

South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...

SK Chemicals introduces Tiglutik, treatment for Lou Gehrig's disease

SK Chemicals said on Monday that it is strengthening its portfolio of neurological diseases by introducing Tiglutik (riluzole), Lou Gehrig's disease...

Korean firms head to CES 2023 to showcase innovative technologies

LAS VEGAS, NV – A growing number of South Korea’s leading companies and startups are heading to CES 2023, the world’s largest tech...

GI Cell wins approval for human cell management from Korean regulator

GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...